首页> 外文期刊>Cell transplantation >Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules.
【24h】

Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules.

机译:糖尿病大鼠间充质干细胞和胰岛的联合移植:通过天然分子预处理的人脂肪组织衍生的干细胞改善的胰岛移植血运重建和功能。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypoxia plays an important role in limiting the engraftment, survival, and function of intrahepatically transplanted islets. Mesenchymal stem cells (MSCs) were recently used in animal models of islet transplantation not only to reduce allograft rejection but also to promote revascularization. Among different possible origins, adipose tissue represents a novel and good source of MSCs. Moreover, the capability of adipose tissue-derived stem cells (ASCs) to improve islet graft revascularization was recently reported after hybrid transplantation in mice. Within this context, we have previously shown that hyaluronan esters of butyric and retinoic acids can significantly enhance the rescuing potential of human MSCs (hMSCs). Here we evaluated whether ex vivo preconditioning of human ASCs (hASCs) with a mixture of hyaluronic (HA), butyric (BU), and retinoic (RA) acids may result in optimization of graft revascularization after islet/stem cell intrahepatic cotransplantation in syngeneic diabetic rats. We demonstrated that hASCs exposed to the mixture of molecules are able to increase the secretion of vascular endothelial growth factor (VEGF) as well as the transcription of angiogenic genes, including VEGF, KDR (kinase insert domain receptor), and hepatocyte growth factor (HGF). Rats transplanted with islets cocultured with preconditioned hASCs exhibited a better glycemic control than rats transplanted with an equal volume of islets and control hASCs. Cotransplantation with preconditioned hASCs was also associated with enhanced islet revascularization in vivo, as highlighted by graft morphological analysis. The observed increase in islet graft revascularization and function suggests that our method of stem cell preconditioning may represent a novel strategy to remarkably improve the efficacy of islets-hMSCs cotransplantation.
机译:低氧在限制肝内移植胰岛的植入,存活和功能中起重要作用。间充质干细胞(MSCs)最近被用于胰岛移植的动物模型中,不仅可以减少同种异体移植的排斥反应,而且可以促进血运重建。在不同的可能起源中,脂肪组织代表了MSC的一种新颖而良好的来源。此外,最近报道了在小鼠中进行异种移植后,脂肪组织干细胞(ASCs)改善胰岛移植血管重建的能力。在此背景下,我们先前已经证明,丁酸和视黄酸的透明质酸酯可以显着增强人类MSC(hMSC)的抢救潜力。在这里,我们评估了透明质酸(HA),丁酸(BU)和视黄酸(RA)的混合物对人ASC(hASCs)的离体预处理是否可以优化同基因糖尿病患者胰岛/干细胞肝内共移植后的移植血管重建大鼠。我们证明了暴露于分子混合物的hASCs能够增加血管内皮生长因子(VEGF)的分泌以及血管生成基因的转录,包括VEGF,KDR(激酶插入域受体)和肝细胞生长因子(HGF) )。胰岛移植与预适应的hASCs共培养的大鼠显示出更好的血糖控制效果,而胰岛和对照hASCs则等量移植。如移植形态分析所强调的,与预处理的hASCs共移植还与体内胰岛血管重建增强有关。观察到的胰岛移植物血运重建和功能的增加表明,我们的干细胞预处理方法可能代表了一种显着提高胰岛-hMSCs共移植功效的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号